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Development of the nervous system begins with neu-
ral induction,which is controlledbycomplex signaling
networks functioning in concert with one another.
Fine-tuning of the bone morphogenetic protein
(BMP) pathway is essential for neural induction in the
developing embryo. However, the molecular mecha-
nisms bywhich cells integrate the signaling pathways
that contribute to neural induction have remained un-
clear. We find that neural induction is dependent on
the Ca2+-activated phosphatase calcineurin (CaN).
Fibroblast growth factor (FGF)-regulated Ca2+ entry
activatesCaN,whichdirectly andspecifically dephos-
phorylatesBMP-regulatedSmad1/5proteins.Genetic
and biochemical analyses revealed that CaN adjusts
the strength and transcriptional output of BMP
signaling and that a reduction of CaN activity leads
to an increase of Smad1/5-regulated transcription.
As a result, FGF-activated CaN signaling opposes
BMPsignaling during gastrulation, thereby promoting
neural induction and the development of anterior
structures.
INTRODUCTION
Embryonic development requires the concerted actions of multi-
ple signaling pathways to control complex gene regulatory
networks, which govern cell-fate decisions. The earliest step in
the development of the nervous system, which is called ‘‘neural
induction,’’ is the acquisition of a neural cell fate by a subset
of ectodermal cells during gastrulation. Previous studies have
shown that neural induction is a dynamic process, which requires
the integration of a number of signaling pathways, including
inhibition of the bone morphogenetic protein (BMP) pathway
(so-called default model) as well as coordinated regulation of
fibroblast growth factor (FGF), Ca2+, and Wnt signaling (Levine
and Brivanlou, 2007; Stern, 2005; Webb et al., 2005). However,
it remains unresolved how these signaling pathways are inte-
grated to induce the earliest neuroectodermal precursors.
Downregulation of BMP signaling within the prospective
neural plate is the key step in neural induction and conservedfrom invertebrates to vertebrates. BMP signaling functions in a
dose-dependent manner and is therefore tightly regulated during
development to adjust pathway activity according to spatial and
temporal context. This is well illustrated by mutant mouse lines
with either increased or decreased BMP activity. Increased ac-
tivity results in truncation of anterior structures and defects of
forebrain development, while reduced activity leads to expan-
sion of anterior neuroectoderm (Bachiller et al., 2000; Davis
et al., 2004).
As a member of the transforming growth factor b (TGF-b) su-
perfamily, BMP transmits intracellular signals through Smad pro-
teins: receptor-regulated Smads (R-Smads; Smad1/5/8 for BMP
and Smad2/3 for TGF-b/Nodal/Activin), common Smad4, and
inhibitory Smads (Smad6/7). R-Smads have two conserved do-
mains, MH1 (N) andMH2 (C), which are connected by a linker re-
gion. Upon ligand binding, the C-terminal SXS motif of R-Smads
is phosphorylated by the BMP receptor I kinase. This phosphor-
ylation event triggers a conformational change of R-Smads
resulting in nuclear translocation and activation of BMP-respon-
sive genes (Feng and Derynck, 2005). BMP signaling is in-
hibited by extracellular antagonists, by interaction of R-Smads
with Smad6/7, and by phosphorylation of the linker region of
R-Smads, which promotes cytoplasmic retention and proteaso-
mal degradation, thereby decreasing the pool of R-Smads (Feng
and Derynck, 2005; Kretzschmar et al., 1997; Sapkota et al.,
2007). The FGF and Wnt pathways have been shown increase
phosphorylation of the linker region of R-Smads, thus antago-
nizing BMP signaling during neural induction of amphibian and
chick embryos (Fuentealba et al., 2007; Kuroda et al., 2005;
Pera et al., 2003).
Another key signaling pathway implicated in the regulation of
neural induction is Ca2+ signaling. It has been shown that an in-
crease of intracellular Ca2+ ([Ca2+]i) in the dorsal ectoderm of
amphibian gastrulae is critical for neural induction (Batut et al.,
2005; Leclerc et al., 2000, 2011; Moreau et al., 1994). Influx of
extracellular Ca2+ via L-type Ca2+ channels and transient recep-
tor potential (Trp) channels as well as inositol 1,4,5-trisphos-
phate (IP3)-regulated Ca
2+ release from intracellular stores is
thought to underlie the increase of [Ca2+]i during neural induction
in amphibian embryos (Ault et al., 1996; Lee et al., 2009).
Although the key step in the activation of BMP-regulated tran-
scription is C-terminal phosphorylation of R-Smads by the BMP
receptor, the reversal of Smad phosphorylation as a regulatory
mechanism and the identity of Smad-specific phosphatases
remain elusive. Although the existence of nuclear phosphatasesNeuron 82, 109–124, April 2, 2014 ª2014 Elsevier Inc. 109
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date phosphatases have been suggested by in vitro studies,
mouse molecular genetics have thus far not provided a link to
BMP signaling or a strong argument for or against the relevance
these phosphatases in vivo (Bruce and Sapkota, 2012).
Calcineurin (CaN) is a Ca2+/calmodulin (CaM)-dependent
serine/threonine phosphatase, composed of a regulatory (CnB)
and a catalytic (CnA) subunit, which is activated by an increase
of [Ca2+]i. Three genes encode the catalytic subunit, CnA (CnA
a, b, g), whereas two genes, one ubiquitously expressed somatic
(CnB1) and the other testis specific (CnB2), encode the regulato-
ry subunit, CnB. CnA consists of an N-terminal phosphatase
domain, a CnB binding motif, a CaM binding motif, and a C-ter-
minal autoinhibitory domain. CnB, which has four EF-hand Ca2+
binding motifs, is tightly associated with CnA. Binding of Ca2+
and CaM to the CaN phosphatase complex results in displace-
ment of the autoinhibitory element and subsequent activation
of phosphatase activity. Genetic deletion of CnB1 eliminates all
of CaN phosphatase activity in somatic cells (Neilson et al.,
2004). CaN can be activated by Ca2+ entry through calcium
release-activated calcium channels, L-type Ca2+ channels,
Gap junctions, and Trp channels (Bush et al., 2006; Graef
et al., 1999). The membrane signals that have been shown to
activate CaN includemany receptor and nonreceptor tyrosine ki-
nases, membrane depolarization, G protein coupled receptors,
and noncanonical Wnt signals (Wu et al., 2007). CaN has been
shown to regulate a broad spectrum of developmental pro-
cesses by activation of NFAT-dependent transcription but is
also well suited to intercalate with other signaling pathways.
In the present study, we demonstrate that CaN is essential for
neural induction in human and murine embryonic stem cells
(ESCs). We describe an unexpected role for CaN in regulating
the strength and the transcriptional output of BMP signaling
and show that CaN directly dephosphorylates the BMP-regu-
lated Smad1/5 transcription factors. Mice lacking CaN activity
show increased BMP activity and severe defects in the develop-
ment of anterior neural structures. Our findings demonstrate
that FGF-activated Ca2+/CaN signaling antagonizes the BMP
pathway and possibly reconciles the respective roles of FGF,
Ca2+, and BMP signaling during neural induction.
RESULTS
CaN Activity Is Required for Neural Induction during
Embryogenesis
We found that mice carrying a null mutation of CnB1 (Ppp3r1),
which eliminates all CaN activity in somatic cells (Neilson et al.,Figure 1. Anterior Defects in CnB1 Mutant and CsA-Treated Embryos
(A) Scanning electron micrographs of E9.5 embryos; forebrain (arrow).
(B) Pax6 immunostaining of E9.0 sagittal sections.
(C–F) qRT-PCR analysis of germ layer markers in e7.5 CnB1 control and mutant e
(p = 0.0768). (E) Brachyury (T) (p < 0.0001). (F) Krt8 (p = 0.0295).
(G) Cartoon of in utero CsA treatment. The red region indicates the critical period
(H–K) qRT-PCR analysis of germ layer markers in E7.5 control and CsA-treated e
(p = 0.2673). (J) Brachyury (T) (p = 0.0010). (K) Krt8 (p = 0.7345).
(L) Pax6 immunostaining of E9.0 control and CsA-treated embryos.
Data are shown as mean ± SEM. Scale bar in (B) and (L) represents 100 mm. See2004), displayed morphological defects that affected anterior
neural structures. Scanning electron microscopy images taken
at midgestation (embryonic day 9.5 [E9.5], 22–24 somites)
showed a size reduction of the CnB1 mutant brain, which
affected the prosencephalon most severely. Additional defects
of head structures including the branchial arches, eyes, and fron-
tonasal prominence as well as an overall reduction of body size
could be seen in mutant embryos (Figure 1A). Pax6 staining of
E9.0 (18–20 somites) embryos showed that the prosencephalon
ofCnB1mutant embryos wasmisshapen and reduced to a small
vesicle of thin neuroepithelium (Figure 1B).
The widespread defects in anterior structures seen in the
mutant embryos led us to speculate that the initial specifica-
tion of rostral neuroectoderm might be affected. To determine
whether the morphological defects observed in mutant embryos
start at gastrulation, we examined the expression of germ-layer
markers in neural-plate stage (E7.5) control and mutant em-
bryos. Gastrulation in the mouse embryo begins around E6.0
and results in the generation of the three germ layers (ectoderm,
mesoderm, and definitive endoderm) from which all fetal tissues
will develop (Tam and Loebel, 2007). In CnB1 mutant embryos,
the expression of anterior neuroectoderm markers (FezF1,
FezF2, and Six3) was significantly reduced compared to stage-
matched wild-type littermate controls (Figure 1C). In contrast,
expression levels of the mesodermal marker Brachyury (T) and
ectodermal marker Krt8 were increased in mutant embryos,
while there was no significant difference in the expression of
the endodermal marker Gata6 (Figures 1D–1F).
To determine the time during development when CaN
signaling was essential, we used pharmacologic inhibition of
CaN with the highly specific and rapidly acting inhibitor of CaN
phosphatase activity, cyclosporin A (CsA). CsA and FK506 are
highly lipophilic, microbial products, which pass through the
cell membrane, placenta, or blood-brain barrier. They bind
to intracellular immunophilins, producing inhibitory complexes
that block CaN phosphatase activity at nanomolar concentra-
tions. The exquisite specificity of CsA and FK506 for CaN is
based upon the large composite surface used to bind the CaN
complex (Griffith et al., 1995). CsA has been a valuable tool to
dissect developmental roles of CaN in vitro and in vivo. In previ-
ous studies, we and others have found that in vivo treatment of
mice with CsA or FK506 phenocopies the null mutation of
CnB1 in a number of systems including vascular, lymphocyte,
heart valve, neural, and coronary artery development (Chang
et al., 2004; Graef et al., 2001, 2003; Quadrato et al., 2012; Zeini
et al., 2009). Injection of CsA into pregnant mice at E6.25 and
E6.75 reproduced the developmental defects seen in CnB1mbryos. (C) Fezf1 (p = 0.0028); Fezf2 (p = 0.0011); Six3 (p = 0.0103). (D) Gata6
during which CaN activity is required in the developing embryo.
mbryos. (H) Fezf1 (p = 0.0230); Fezf2 (p = 0.0086); Six3 (p = 0.0001). (I) Gata6
also Figure S1.
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able in gene expression from CnB1 mutant embryos (Figures
1H–1K). As observed in the CnB1 mutant embryos, the expres-
sion of neuroectodermal markers Six3, FezF1, and FezF2 was
dramatically reduced while expression of the mesodermal
marker, Brachyury, was increased when CaN activity was in-
hibited on day 6 of gestation. Pax6 staining of CsA-treated
embryos revealed similar defects in forebrain development as
observed in CnB1 mutant animals (Figure 1L). These findings
pointed toward a role of CaN in embryonic patterning during
gastrulation. To examine the CnB1 expression pattern during
early embryonic development, we performed immunohisto-
chemical analysis and quantitative RT-PCR (qRT-PCR) studies
of early mouse embryos. The highest levels of CnB1 protein
expression were seen in the hypoblast of E6.5 embryos (Fig-
ure S1A available online). CnB1 mRNA was expressed during
gastrulation and in murine ESCs, while CnB2 was undetectable
in somatic tissues and ESCs (Figures S1B and S1C).
Calcineurin Activity Is Required for Neural
Differentiation of ESCs
The molecular analysis of signaling in the early mouse embryo is
limited by size and relative inaccessibility of the mammalian gas-
trula. In vitro differentiation of ESCs to neural progenitor cells
(NPCs) provided a means for biochemical analysis of the mech-
anism of action of CaN in early neural development. Embryoid
body (EB) cultures of ESCs recapitulate the process of germ-
layer formation and generate cell lineages in a defined temporal
pattern. Because Sox1 is one of the earliest neural markers
expressed specifically in the neural plate, we used Sox1-GFP
knockin murine ESCs (mESCs) to monitor and quantify neural
induction in vitro (Ying et al., 2003) (Figure 2A).
Using fluorescence-activated cell sorting (FACS), we found
that inhibition of CaN with a combination of FK506 and CsA
(FK/CsA) during the differentiation period (day 3 [d3]–d12)
severely compromised differentiation of ESCs into GFP-positive
NPCs (Figures 2B and 2C). We used a combination of FK506 and
CsA, because the level of CaN expression in murine EBs (mEBs)
is high (for a more detailed explanation, see Supplemental Infor-
mation). The concentration of inhibitors used was based on theirFigure 2. Calcineurin Activity Is Required for Neural Differentiation of
(A) Schematic representation of in vitro ESC to neural differentiation using Sox1-
(B) Quantification of Sox1-driven GFP (=Sox1-GFP) expression on d12 by FACS a
(FK/CsA), 3.84%.
(C) Sox1-GFP expression of NT and FK/CsA-treated (d3–d12) cells on d12.
(D) Critical time window during which calcineurin (CaN) activity is necessary fo
windows (gray bars) of in vitromurine ESC differentiation. On d12, GFP expression
neural induction.
(E) Quantification of Sox1-GFP expression on d12 by FACS analysis (mean ± SEM
data were normalized to the NT control group. p value compared to NT: FK/CsA d3
p = 0.0097; CsA d3–d8 (n = 3), p = 0.0028.
(F) Confocal immunofluorescence images of NT and FK/CsA-treated (d3–d8) cel
Scale bar represents 10 mm.
(G) Immunofluorescence images of NT and FK/CsA-treated H1 cells on d11 of h
resents 50 mm.
(H and I) Microarray gene expression profiles of indicated genes on d4, d6, d8, and
from d3 to d8. (H) Neuroectoderm markers. (I) Pluripotency, endoderm, mesode
experiments of in vitro differentiation. Data are shown as mean ± SEM.
See also Figure S2.ability to completely inhibit CaN phosphatase activity, using the
phosphorylation state of the well-established CaN substrate,
NFATc4, as a readout for CaN activity (Figure S2A). The failure
of neural differentiation of FK/CsA-treated mESCs was consis-
tent with the defects in neural development observed in CnB1
mutant and CsA-treated embryos and suggested that CaN activ-
ity is required for neural differentiation of mESCs.
To gain insight into the molecular mechanisms underlying
CaN’s role in neural induction, we defined the critical time win-
dow during ESC to neuron differentiation that was sensitive to
inhibition of CaN activity (Figure 2D). Addition of FK/CsA for
defined periods followed by compound washout revealed that
FK/CsA treatment from d3 to d8 inhibited ESC differentiation
into Sox1-GFP-positive NPCs (Figure 2E). Subsequent culture
for 7–16 days without FK/CsA did not reverse this block (Figures
2F and S2F). Exposure to FK/CsA after 8 days of differentiation
failed to inhibit GFP expression (Figure 2E). As further confirma-
tion that the effect of FK/CsA on neural induction was the result
of inhibiting CaN activity, we used a cell-permeable dimer of
FK506, FK1012 (Spencer et al., 1993), which interacts with
FKBP12 at a stoichiometry of 1:2 (Kd = 0.5 nM) but does not
bind to or inhibit CaN. This compound had no effect on neural in-
duction of mESCs (Figure 2E). Pharmacologic inhibition of CaN
had a dose-dependent effect upon neural induction (Figures
S2B and S2C), which further confirmed that that the effect on
neural induction seen following treatment of EBs with FK/CsA
was indeed due to inhibition of CaN activity.
Costaining mEB cultures on d12 for the early neuroectodermal
markers Pax6 and Nestin corroborated the FACS and western
blot data. CaN inhibition from d3 to d8 resulted in the absence
of NPCs double positive for Sox1-GFP and Pax6 or Nestin (Fig-
ure S2E). After dissociation and further culture for 3 days, non-
treated (NT) cells underwent efficient neurogenesis leading to
the generation of bIII-tubulin-positive postmitotic neurons. How-
ever, cultures that were exposed to FK/CsA from d3 to d8
showed no bIII-tubulin-positive cells on d15 (Figure 2F) or on
d24 (Figure S2F), indicating that inhibition of CaN did not simply
delay neural induction.
To investigate the role of CaN signaling in human neuroecto-
derm formation, H1 human ESCs (hESCs) were differentiatedMurine and Human ESCs
GFP reporter murine ESCs.
nalysis. % of GFP-positive cells: NT, 27.5%; d3–d12 FK506- and CsA-treated
r neural induction. Cells were treated with FK/CsA during the indicated time
of each group wasmeasured by FACS analysis and/or western blot to quantify
). Cells were treated with indicated molecules during d3–d12 or d3–d8. FACS
–d12 (n = 5), p < 0.0001; FK/CsA d3–d8 (n = 5), p < 0.0001; FK506 d3–d8 (n = 3),
ls on d15 using antibodies against GFP and pan-neuronal marker b-III-tubulin.
ESC differentiation using antibodies against SOX2 and PLZF. Scale bar rep-
d12 cells of in vitro murine ESC differentiation. CaNwas inhibited with FK/CsA
rm, and ectoderm markers. Samples were collected from three independent
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ized by the formation of neural rosette structures that expressed
Sox2 and PLZF (Figure 2G, upper panel) on d11 of human EB dif-
ferentiation. Treatment of hESCs with FK/CsA blocked the in-
duction of Sox2+/PLZF+ NPCs and resulted in the appearance
flat cuboidal cells (Figure 2G, lower panel).
Microarray analysis ofmEBs on d4, d6, d8, and d12 of differen-
tiation revealed that CaN inhibition specifically reduced neural
lineage markers, which were expressed at very low levels on
d12 in FK/CsA-treated cells when compared to NT controls (Fig-
ures 2HandS2I–S2K). In contrast, the expression of pluripotency
(Nanog, Oct4, and Rex1), mesoderm (Brachyury, Gsc, and
GATA1), endoderm (Sox7, Sox17, HNF1a), and ectoderm (Krt8,
Krt18,Tcfap2a) markerswasnot significantly changedbyCaN in-
hibition during mEB differentiation (Figures 2I and S2L). NFATc4
phosphorylation and Sox1, GFP, Nova, and BLBP were used to
monitor CaN activity and neural differentiation in samples used
formicroarray analysis (FiguresS2DandS2H–S2J). These results
indicate that lack of CaN activity altered both murine and human
cells in a manner that prevented later neuronal differentiation.
FGF8-Regulated Ca2+ Entry Enhances Neural Induction
Because CaN is activated by signals that increase the concen-
tration of [Ca2+]i, we sought to define the source of the Ca
2+-
signal that activated CaN during neural induction. A number of
studies support a role for FGF signaling during acquisition of a
neural cell fate in vivo and in vitro (De Robertis and Kuroda,
2004; Stern, 2005; Wilson et al., 2000), but the emerging picture
of how FGFs promote neural induction seems to be complex.
During embryogenesis, Fgf8 and Fgf17 are expressed in pre-
streak- and streak-stage embryos (Crossley and Martin, 1995),
and FGF signaling in epiblast cells was found to repress BMP4
and BMP7 mRNA expression (Wilson et al., 2000). FGFs have
also been shown to attenuate BMP signaling intracellularly and
to increase the size of the neural plate in amphibian embryos
(Pera et al., 2003) as well as to act independently of BMPs
(Delaune et al., 2005; Stern, 2005). In addition, it has been shown
that treatment of hESCs with a FGF receptor (FGFR) tyrosine
kinase inhibitor blocks neural induction in a dose-dependent
manner, suggesting that FGF signaling is also critical for neural
induction of hESCs (LaVaute et al., 2009).
FACS analyses showed that treatment of mEBswith FGF8 and
FGF17 during the FK/CsA-sensitive time period, d3–d8, signifi-
cantly increased the number of Sox1-GFP-positive cells (Fig-
ure 3A) compared to NT samples. Western blot analysis of these
cells confirmed increased expression of GFP and Sox1 (Fig-
ure 3B). In contrast, treatment with FGF2 and FGF4 had a small
inhibitory effect (Figures 3C and 3D), consistent with recent
observations made during neural differentiation of human
ESCs (Greber et al., 2011). These findings align well with distinct
functions of FGF8 and FGF2 during early neural development (De
Robertis and Kuroda, 2004; Stern, 2005).
Treatment of EBs with FGF8/17 could not bypass the require-
ment for CaN signaling during the differentiation of both hESCs
and mESCs, and enhanced neural induction by FGF8 required
CaN activity (Figures 3E–3G). There are two possible explana-
tions for this finding. CaN activity could be required for cells to
be competent to respond to FGF8 signaling, or CaN could be a114 Neuron 82, 109–124, April 2, 2014 ª2014 Elsevier Inc.critical signaling intermediate in the intracellular FGF8 signal
transduction cascade. The mRNA expression levels of FGFRs
as well as of a number of known FGF-regulated genes were
not changed in the FK/CsA-treated samples (Figure S3). In addi-
tion, we have previously found that FGF8 directly activates CaN
signaling in embryonic cortical neurons (Arron et al., 2006).
Therefore, we concluded that CaN might be a key mediator of
FGF8 signaling during neural induction.
It has been demonstrated that FGF signaling can promote
Ca2+ entry through Trp channels and that CaN is activated by
Trp-channel mediated rise of intracellular Ca2+ (Fiorio Pla et al.,
2005; Poteser et al., 2011). Therefore, we tested whether Trp
channels were critical for differentiation of ESCs to NPCs. Phos-
pholipase-Cg1 (PLCg1) is known to be recruited via its SH2
domain to phosphotyrosine in the cytoplasmic tail of FGFRs,
resulting in PLCg1 activation, stimulation of phosphatidylinositol
(PI) hydrolysis, and the generation of the two second messen-
gers, diacylglycerol (DAG) and IP3 (Mohammadi et al., 1991).
The Trp cation channel family (Trpc) is subdivided into four
groups: Trpc1; Trpc2; Trpc4 and c5; and Trpc3, c6, and c7.
The Trpc3, c6, and c7 subfamily is directly activated by DAG
(Hofmann et al., 1999), thereby coupling receptor/PLCg
signaling to Ca2+ entry. We found that inhibition of Trpc3 with
the small molecule Pyr3 (Kiyonaka et al., 2009) blocked neural in-
duction as well as the increase in neural differentiation brought
about by FGF8 treatment (Figure 3G). These findings suggested
that Ca2+ entry via Trpc3 might be critical for the activation of
CaN by FGF8 during neural induction.
Inhibition of CaN Enhances BMP Signaling during ESC
Differentiation
Microarray analysis of genes differentially expressed in FK/CsA-
treated and NT mEBs during the time period sensitive to CaN
inhibition (d3–d8) revealed a significant enrichment of BMP-
responsive genes, including Msx1, which had previously been
shown to inhibit neuralization (Suzuki et al., 1997) (Figures 4A
and S4A; Table S1). Consistent with the increased mRNA levels
of Bmp4 (Figure 4A), which is known to be under positive-feed-
back regulation of BMP signaling (Karaulanov et al., 2004; Ramel
and Hill, 2012), we found that treatment of mEBs with FK/CsA
from d3 to d8 of differentiation increased the expression of
genes within the coregulated Bmp4 synexpression cluster
such asSmad6,Msx1, andMsx2, which are direct transcriptional
targets of BMP4-Smad1/5 signaling (Figures 4A and S4A). These
results pointed toward increased activation of the BMP pathway
following inhibition of CaN activity during ESC differentiation.
This finding was intriguing, given the known link between BMP
signaling and neural induction. Seminal experiments, which led
to the so-called default model of neural induction, showed that
inhibition of BMP signaling during gastrulation was necessary
and sufficient for neural induction in frog embryos. Secreted fac-
tors such as noggin or chordin directly bind to and neutralize
BMPs during gastrulation and induce neural tissue in Xenopus
embryos (Hemmati-Brivanlou and Melton, 1994; Lamb et al.,
1993; Sasai et al., 1995). Knockout studies in mice have
shown that the extracellular BMP inhibitors chordin and noggin
are functionally redundant during early embryogenesis and are
required for anterior neural differentiation (Bachiller et al., 2000).
Figure 3. FGF8-Regulated Ca2+ Entry En-
hances Neural Induction
(A) Quantification of Sox1-GFP expression by
FACS. % of GFP positive cells: NT, 32.3%; FGF8,
50.5%; FGF17, 49.5%.
(B) Immunoblot analysis of Sox1-GFP and Sox1
after treatment with FGF8a, FGF8b, or FK/CsA.
Brg1 and Hsp90 are loading controls.
(C) Quantification of Sox1-GFP expression by
FACS. % of Sox-1 GFP positive cells: NT, 32.3%;
FGF2, 21.9%; FGF4, 30%.
(D) Immunoblot analysis of Sox1-GFP and Sox1
after treatment with FGF2 and FGF4.
(E) SOX2 and PLZF immunostaining of hESC
treated with the indicated molecules and har-
vested on d11 of differentiation. Scale bar repre-
sents 50 mm.
(F) Quantification of Sox1-GFP expression by
FACS analysis (mean ± SEM). FACS data were
normalized to the NT control group.
(G) Immunoblot analysis of GFP and Sox1
expression after treatment with the indicated
molecules.
In (A)–(D), (F) and (G), cells were treated with the
indicated growth factors or small molecules during
d3–d8 of in vitro murine ESC differentiation and
harvested on d12 for analysis. See also Figure S3.
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d3 to d8 were equivalent, and both prevented differentiation of
mESCs into Sox1-GFP-positive NPGs (Figure 4B). The oppositeNeuron 82, 109–effect was seen in cultures treated with
the BMP inhibitor Noggin (Figure 4B).
Similar to the time window that we iden-
tified as critical for CaN activity (Figure 2),
the effectiveness of BMP treatment in
altering cell fate during mESC differentia-
tion has been reported to be limited to a
period prior to the onset of neural differ-
entiation (Finley et al., 1999). In the early
mouse embryo, Flk1(Kdr), which at later
stages is a well-known marker for cardio-
vascular and hematopoietic progenitors,
is highly expressed in multipotent meso-
dermal progenitors that exit from the
posterior primitive streak (Ema et al.,
2006). Inhibition of CaN activity or expo-
sure to BMP4 led to a dramatic increase
of cells expressing Flk1, while Noggin in-
hibited differentiation into Flk1-positive
cells (Figures 4B and S4A). In addition,
FK/CsA treatment increased the expres-
sion of posterior primitive streak markers
(Mesp1 and HoxB1), suggesting the
enrichment of more posterior mesoderm
populations, while anterior streak makers
(Cer1 and Chrd) were reduced (Fig-
ure S4A). Similar observations had been
made during in vitro differentiation ofESCs in the presence of BMP4 (Nostro et al., 2008). The high
expression of Flk1, along with the increased expression of
Tie2, PFGRa, and Nrp1 at d12, might reflect enhanced124, April 2, 2014 ª2014 Elsevier Inc. 115
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lineage. Markers that delineate other cell types that arise from
Flk1-positive mesodermal progenitors, including hematopoietic
(Tal1, Itga2b, Gata1, Runx1, and Hbb-y), myocardial (Nkx2-5,
Mef2C, and Tnnt2), paraxial, and somitic lineages (Tbx18,
Tbx6, and Pax3), were not changed in FK/CSA-treated cultures
at d12 (Figure S4A). These data suggest that inhibition of
CaN increases the intensity of BMP signaling during mESC
differentiation.
CaN Antagonizes BMP Signaling by Direct
Dephosphorylation of Smad1/5 Proteins
To further delineate the functional relationship between CaN and
BMP signaling, we tested whether inhibition of BMP signaling
proximal to binding its receptor with the BMP antagonist,
Noggin, could bypass the requirement for CaN phosphatase ac-
tivity during neural differentiation of mESCs. We found that, even
in the presence of exogenously added Noggin, FK/CsA treat-
ment reduced differentiation of mESCs into Sox1-GFP-positive
NPCs (Figure 4C). This result suggested that CaN might modu-
late the BMP-signaling pathway after binding of BMP proteins
to the BMP receptor complex.
Signal transduction pathways are often regulated by dynamic
interplay between protein kinases and phosphatases. Thus, we
focused our attention on the phosphorylation state of Smad1/5
proteins. Phosphorylations of serine residues in the linker
(S206) and C-terminal (S463/465) region of the BMP-regulated
Smad1/5 proteins regulate their transcriptional activity and sta-
bility (Massague´ et al., 2005). The level of C-terminal phosphor-
ylation (pSmad1/5C-term), which regulates nuclear translocation
and activation of Smad-regulated transcription, determines the
intensity of BMP signaling (Feng and Derynck, 2005). Treatment
of mEBs with FK/CsA resulted in a pronounced increase of
pSmad1/5C-term (Figure 4D, lane 2). As expected, treatment
with Noggin reduced pSmad1/5C-term to an undetectable level
(Figure 4D, lane 3). The level of phosphorylation following treat-
ment with Noggin in the presence of FK/CsA was lower than in
NT samples but higher than in samples treatedwith Noggin alone
(Figure 4D, lane 4). The differences in pSmad1/5C-term levels
might account for the dramatic differences in the number of
Sox1-GFP-positive cells seen on d12 (Figure 4C). These epis-
tasis experiments suggested that C-terminal phosphorylation
sites in Smad1/5might be critical targets of CaN signaling during
ESC to NPC differentiation.Figure 4. CaN Antagonizes BMP Signaling during Neural Differentiatio
(A–C) Murine ESCs were treated with the indicated molecules from d3 to d8 of in
genes on d4, d6, d8, and d12. Graphs are shown as mean ± SEM. (B) Quant
Quantification of Sox1-GFP-positive cells on d12 by FACS analysis. % of GFP-pos
BMP4, 0.951%.
(D) Immunoblot analysis shows the level of pSmad1/5C-term, Smad1, and Smad5
(E) Immunoblot analysis of nuclear and cytoplasmic fractions (d5 EBs) for pSmad
loading control), and b-tubulin (cytoplasmic loading control). Cells were treated w
(F) Immunoblot analysis of HaCaT whole-cell extracts for pSmad1/5 C-term, Smad
(G) The effect of constitutively active CaN on pSmad1/5 C-term in d2 human EBs
respectively. Immunoblot analysis shows the level of pSMAD1/5C-term, SMAD1/5
(H) In vitro phosphatase assay using nuclear and cytoplasmic extracts from BMP4
Smad1/5, TBP, and tubulin after the assay. CIP, calf intestinal alkaline phosphat
See also Table S1 and Figure S4.To examine the subcellular localization of pSmad1/5C-term
after inhibition of CaN, EBs were treated with for 1 hr with
FK/CsA, separated into nuclear and cytosolic fractions, and
analyzed for levels of total Smad1/5 and pSmad1/5C-term (Fig-
ure 4E). Endogenous CaN in mEBs was present in both the nu-
clear and cytoplasmic fractions (Figure 4E). We found that short
treatment with FK/CsA or BMP4 resulted in increased pSmad1/
5C-term, which was most pronounced in the nuclear fraction.
Treatment with okadaic acid (OA), which inhibits the phospha-
tases PP1 and PP2A, had no effect on pSmad1/5C-term, which
indicated that the effect of CaN on pSmad1/5C-term was direct
and not mediated by modulation of PP1 or PP2A activity (Fig-
ure 4E). Inhibition of CaN had only a minor effect on linker
phosphorylation (Figure 4E). Total Smad1/5 protein levels did
not change during this period. Interestingly, inhibition of CaN
had no effect on the level of C-terminal phosphorylation of the
Nodal/TGF-b/Activin-regulated R-Smads, Smad2/3 (Figure S5).
These data suggest that the effects of CaN were exclusive
to BMP-regulated R-Smads. To investigate whether regulation
of Smad1/5 by CaN is unique to EBs, we examined HaCaT cells.
Consistent with regulation of the intensity of the BMP signal
by CaN, short-term treatment of HaCaT cells with FK/CsA
increased basal pSmad1/5C-term as well as pSmad1/5C-term
following stimulation with low levels of BMP2 (Figures 4F and
S4B) and slowed the decay of the pSmad1/5C-term signal
following the washout of BMP2 (Figure S4C).
Increased Bmp4 mRNA expression, which we observed
following prolonged inhibition of CaN activity (Figure 4A), could
have auto/paracrine effects on the level of pSmad1/5C-term.
Thus, we examined whether short-term FK/CsA treatment,
which resulted in a profound increase of pSmad1/5C-term, had
an effect on BMP4 transcription (Figures 4D–4F, S4B, and
S4C). We found no increase of Bmp4 mRNA levels after short-
term (1 hr) inhibition of CaN activity (Figure S4D), suggesting
that the role of CaN in the regulation of Smad1/5C-term phosphor-
ylation is direct.
As an alternative approach to address the question whether
CaN directly regulates Smad1/5C-term phosphorylation, we
examined pSmad1/5C-term levels in hESCs expressing a consti-
tutively active form of CaN. Active CaN is a truncated form of
the catalytic Aa subunit, which lacks the autoinhibitory and a
portion of the CaM-binding domain but retains the CnB-binding
domain (O’Keefe et al., 1992). This deletion renders CaN activity
independent of Ca2+. We infected hESCs with lentiviral vectorsn of ESCs
vitro differentiation. (A) Microarray gene expression profiles of BMP-regulated
ification of Sox1-GFP- and Flk1-positive cells on d12 by FACS analysis. (C)
itive cells: NT, 27.5%; FK/CsA, 4.68%; Noggin, 74%; Noggin+FK/CsA, 54.2%;
in d6 EBs treated with the indicated molecules for 1 hr.
1/5C-term, pSmad1linker, Smad1/5, CnB1, TATA-binding protein (TBP) (nuclear
ith the indicated molecules for 1 hr. OA, okadaic acid.
1, and actin. BMP2 and FK/CsA treatment: 15 min.
differentiated from hESCs expressing control and constitutively active CaN,
, CnB1, NFATc4, CnA, GFP (expression control), and HSP90 (loading control).
-stimulated d8 EBs. Immunoblot analysis detects the levels of pSmad1/5C-term,
ase. See Experimental Procedures for details.
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the normalized level (normalized on the expression of Smad1/5)
of pSmad1/5C-term was 4-fold lower in cells expressing active
CaN compared to control cells (Figure 4G, top left panel). The
phosphorylation state of the well-characterized CaN substrate
NFATc4 was used as a positive control (Figure 4G, top right
panel).
We next determined whether Smad1/5 proteins were direct
substrates for CaN and tested whether CaN dephosphorylated
Smad1/5 in vitro (Figure 4H). To obtain Smad1/5 proteins that
were phosphorylated under physiological conditions, we pre-
pared extracts from d8 mEBs that were stimulated for 1 hr
with 50 ng/ml BMP4. These extracts, which contained abundant
amounts of pSmad1/5C-term, were used as the substrate for
in vitro phosphatase assays with recombinant CaN and CaM.
Incubation of both nuclear and cytoplasmic extracts resulted
in efficient C-terminal dephosphorylation of Smad1/5 by CaN
(Figure 4H, top panel). Calf intestinal phosphatase, which is a
robust, nonspecific phosphatase that dephosphorylates nucle-
otides, proteins, and alkaloids, was used as a positive control.
The level of total Smad1/5 protein was not changed by incuba-
tion with CaN, indicating that the loss of the pSmad1/5C-term
signal seen in the immunoblot (Figure 4H, top panel) was due
to direct dephosphorylation and not degradation of Smad1/5
(Figure 4H, second panel). Taken together, these results provide
strong evidence that Smad1/5 proteins are direct targets of
CaN phosphatase activity and indicate that during the ESC to
NPC differentiation period, CaN dampens BMP signaling by
dephosphorylating pSmad1/5C-term, thus promoting induction
of a neural cell fate.
Smad1/5 Proteins Are the Critical Targets of CaN during
Neural Induction
One of the best-characterized developmental targets of CaN is
the NFATc family of transcription factors. To test whether the
BMP-regulated Smad1/5 proteins are indeed the critical targets
of CaN phosphatase activity during neural induction, we gener-
ated mice that carry mutant alleles of all four NFATc genes,
NFATc1L/L c2/c3L/Lc4/, which we will refer to as QKOcond.
In order to investigate the role of NFAT-dependent transcription
and to completely remove all four NFATc proteins during neural
induction, we prepared an ESC line from the QKOcond mice. We
transfected this line with a 4-hydroxytamoxifen (4-OHT)-regu-
lated form of Cre recombinase, which enabled us to acutely
delete NFATc1 and NFATc3 by homologous recombination
following 4-OHT treatment. We confirmed the lack of NFATc2
and NFATc4 expression and the 4-OHT-dependent deletion of
NFATc1 and NFATc3 in the QKOcond ESC line by qRT-PCR
and western blotting (Figures 5A and S6). Inhibition of CaN activ-
ity with FK/CsA in EBs, which lacked all four NFATc proteins, re-
sulted in a 3- to 5-fold increase of pSmad1/5C-term (normalized
to Smad1/5 expression levels) (Figure 5A, lane 4). These results
indicate that the effect of CaN on C-terminal phosphorylation of
Smad1/5 was independent of the expression of NFATc proteins.
Immunoblot analysis of Sox1 expression on d12 of neural induc-
tion showed that neural induction was not impaired in 4-OHT-
treated QKOcond EBs (Figure 5B). Treatment of QKOcond EBs
with FK/CsA blocked neural induction, as evidenced by the118 Neuron 82, 109–124, April 2, 2014 ª2014 Elsevier Inc.lack of Sox1 expression (Figure 5B), which is consistent with
the hypothesis that Smad1/5 rather than NFATc proteins are
the critical targets of CaN phosphatase activity during neural
induction.
To further investigate the relationship between CaN and
BMP signaling during neural induction, we asked whether CaN
activity was required in the absence of BMP signaling. This
was addressed by making use of small-molecule inhibitors of
the BMP type I receptors ALK2, ALK3 and ALK6, which block
BMP-mediated phosphorylation of Smad1/5/8 (Yu et al., 2008).
FACS analysis of Sox1-driven GFP expression following neural
differentiation of 46C cells showed that both Dorsomorphin
and LDN193189 strongly enhanced neural induction of mESCs
(Figure 5C). Neither inhibition of CaN signaling nor addition of
FGFs from d3 to d8 had any effect on neural induction when
BMP receptor I kinase activity was fully inhibited with either
Dorsomorphin or LDN193189 (Figure 5C).
Whereas NT hESCs showed increased expression of SOX2
and PLZF following neural differentiation (Figure 5D, first panel),
induction of neuronal markers was not detected in cultures that
were differentiated in the presence of FK/CsA (Figure 5D, second
panel). As observed during neural differentiation of mESCs (Fig-
ure 5C), differentiation of hESCs via the dual SMAD-inhibition
protocol using LDN-193189 and SB431542, which robustly
induced SOX2+/PLZF+ NPCs precursors (Figure 5D, third panel),
also bypassed the need for CaN signaling during neural induc-
tion (Figure 5D, fourth panel).
Given the requirement of Ca2+ for the activation of CaN and
the block in neural induction that we observed following Pyr3
treatment of mEBs from d3 to d8, we tested whether intracellular
Ca2+ levels affected the phosphorylation state of Smad1/5.
Treatment of EBs with the a Ca2+ ionophore dramatically
decreased the level of pSmad1/5C-term, an effect that was
blocked by CaN inhibition (Figure 5E). Similarly, addition of
FGF8 to mEBs also reduced pSmad1/5C-term levels. Because
several FGF family members were expressed at high levels in
mEBs during the critical time window of ESC-to-neuron differen-
tiation (Figure S3), we tested whether inhibition of auto/paracrine
FGF signaling with FGFR-Fc fusion proteins affected the levels
of pSmad1/5C-term. Interestingly, we found that treatment with
FGFR-Fc fusion proteins or Trpc3 inhibition with Pyr3, increased
the levels of pSmad1/5C-term (Figure 5E). These results sug-
gested that the levels of pSmad1/5C-term were modulated by
FGF/ Trpc/Ca2+ dependent activation of CaN.
CaN Opposes BMP Signaling during Early Embryonic
Development
To test whether a loss of CaN activity is correlated with increased
BMP signaling during embryogenesis, we measured the expres-
sion levels of known BMP target genes inCnB1mutant and CsA-
treated embryos. Consistent with the results found during ESC
to NPC differentiation, expression of the BMP-regulated genes,
Smad6 and Mixl1, was significantly increased in CnB1 mutant
E7.5 embryos (Figure 6A). Likewise, Smad6 and Mixl1 in E7.5
embryos that had been treated with CsA in utero on day 6 of
gestation showed significantly increased expression of Smad6
and Mixl1 mRNAs (Figure 6B). In vivo and ex vivo studies
have illustrated the essential role of BMP signaling in early
Figure 5. Smad1/5 Proteins Are the Critical Targets of CaN during Neural Induction
(A and B) in vitro differentiation of a murine ESC line harboring ERT2CreERT2; NFATc1L/L c2/ c3L/Lc4 / in which the floxed alleles ofNFATc1 andNFATc3were
removed by 4-OHT-regulated nuclear import of ERT2CreERT2. 4-OHT was added at the ESC stage and FK/CsA from d3 to d8. (A) Immunoblot analysis of d8 EBs
using antibodies against NFATc3, pSmad1/5C-term, Smad1/5, and actin (loading control). pNFATc3: phosphorylated (arrow), NFATc3: dephosphorylated
(arrowhead); * indicates a nonspecific band. (B) Immunoblot analysis of d12 EBs using antibodies against NFATc3, Sox1, and Hsp90 (loading control).
(C) FACS analysis of Sox1-GFP expression was used to quantify the percentage of neural induction following inhibition of BMP signaling in the presence or
absence of CaN activity or FGF signaling. Cells were treated with indicated molecules during d3–d8. FACS data were normalized to the NT control group.
(D) Inhibition of CaN has no effect on SOX2 and PLZF expression of hESCs in the presence of dual SMAD inhibition with a combination of SB431542, an ALK
inhibitor, and LDN193189, a BMP inhibitor. Scale bar represents 50 mm.
(E) Immunoblot analysis for pSmad1/5C-term, Smad1/5, and actin (loading control) in d4murine EBs treated with the indicatedmolecules. Ionomycin, FK/CsA, and
FGF8: 1 hr; FGFR-Fc and Pyr3: 3 hr.
See also Figures S5 and S6.
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Calcineurin Signaling Antagonizes the BMP Pathwaycardiogenesis. Conditional deletion of BmpR1a in cardiac pro-
genitors prevented formation of the cardiac crescent at E7.5
(four somites) (Klaus et al., 2007), and application of BMP2 or
BMP4 promoted (Schultheiss et al., 1997), while application of
Noggin inhibited (Schlange et al., 2000), cardiac differentiation
in chick embryos. Thus, we examined the mRNA levels of genes
expressed in early cardiac precursors. We found that expressionof the earliest cardiac mesoderm marker, Eomes (Costello et al.,
2011), was significantly increased in CnB1 mutant and CsA-
treated E7.5 embryos (Figures 6A and 6B). Eomes directly acti-
vates Mesp1 expression, which is one of the earliest molecular
markers for cardiac progenitors and amaster regulator of cardio-
vascular differentiation (Bondue et al., 2008). Consistent with the
increased level of Eomes, the mRNA level of Mesp1 was alsoNeuron 82, 109–124, April 2, 2014 ª2014 Elsevier Inc. 119
Figure 6. Increased BMP Signaling in CnB1
Mutant and CsA-Treated Embryos
(A and B) qRT-PCR analysis of BMP-regulated
genes at E7.5 (A) CnB1 control and mutant em-
bryos. Mixl1 (p = 0.0053); Smad6 (p = 0.0030);
Mesp1 (p = 0.0214); Eomes (p = 0.0108). (B)
Control and CsA-treated embryos; pregnant fe-
males were injected with CsA on E6.25 and E6.75.
Mixl1 (p = 0.0002); Smad6 (p = 0.0073);Mesp1 (p =
0.0006); Eomes (p = 0.0002). Data are shown as
mean ± SEM.
(C and D) Immunoblot of NFATc3, pSmad1/
5C-term, Smad1, Smad5, and actin in (C) E7.5
control and CsA-treated embryos; (D) E8.0 CnB1
control and mutant headfolds. pNFATc3: phos-
phorylated (arrow); NFATc3: dephosphorylated
(arrowhead); * indicates a nonspecific band.
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bryos (Figures 6A and 6B).
To establish whether Smad1/5C-term was dephosphorylated
by endogenous CaN during gastrulation, we treated pregnant
females on E7.0 embryos with CsA and harvested the embryos
2 hr after injection. Examination of Smad1/5 C-terminal phos-
phorylation showed a significant increase in pSmad1/5C-term
levels in the treated embryos (Figure 6C). These results indicate
that CaN actively opposes BMP signaling during gastrulation.
To further evaluate the role of endogenous CaN in BMP
signaling during early embryogenesis, we examined Smad1/5
in CnB1 mutant embryos and found increased levels of
pSmad1/5C-term in CnB1 mutant E8.0 headfolds (Figure 6D). In
addition, the level of Sox1 protein expression was reduced in
CnB1 mutants, which might reflect decreased neural induction120 Neuron 82, 109–124, April 2, 2014 ª2014 Elsevier Inc.due to increased activation of BMP
signaling in the absence of CaN.
DISCUSSION
We have presented genetic and pharma-
cologic evidence that signaling through
CaN is critical for neural induction during
embryonic development and ESC differ-
entiation. Our in vitro studies show that
the Ca2+/CaN pathway regulates the
strength of BMP signaling by direct and
specific dephosphorylation of Smad1/5.
We further find that inhibition of CaN
signaling results in a cell-fate change
and directs mESCs toward the cardio-
vascular rather than neural lineage.
Lastly, we demonstrate that endoge-
nously activated CaN dephosphorylates
Smad1/5 during gastrulation. These find-
ings support a model of neural induction
in which activation of CaN by FGF-regu-
lated Ca2+ entry via Trp channels op-
poses BMP signaling (Figure 7). In this
model, Ca2+/CaN functions downstreamof R-Smad phosphorylation, and dephosphorylation of R-Smads
by CaN results in reduction of Smad-regulated transcription.
Placing CaN function downstream of Smad complex formation
allows for precise control of active Smad complexes, which po-
sitions CaN to be a point of convergence for integrating BMP
signaling with other pathways that increase [Ca2+]i.
Calcineurin Signaling Is Required for Neural Induction
Studies of neural induction in several model organisms have lead
to both the default model as well as to more complex instructive
models. In the default model, cells adopt a neural cell fate in
the absence of extrinsic signals. Elegant experiments in frogs
showed that repression of BMP signaling by extracellular
antagonists is required for neural differentiation in the embryo
(Hemmati-Brivanlou and Melton, 1994; Lamb et al., 1993; Sasai
Figure 7. Modulation of BMP Signaling by
FGF/Ca2+/CaN Signaling
Model depicting the proposed mechanism for in-
hibition of BMP signaling by CaN. FGF signaling
triggers an increase of intracellular Ca2+, which
activates the CaN phosphatase complex con-
sisting of CnA, CnB, and CaM. Activated CaN
specifically dephosphorylates pSmad1/5C-term,
thereby opposing BMP signaling. A lack of CaN
activity results in an increase of nuclear pSmad1/
5C-term and an enhanced or ectopic activation
of BMP-regulated transcription. BMPR, BMP re-
ceptor; CnA, calcineurin subunit A; CnB, calci-
neurin subunit B; FGFR, FGF receptor; TRPC,
canonical transient receptor potential.
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Calcineurin Signaling Antagonizes the BMP Pathwayet al., 1995). However, a number of findings have suggested that
the default model might be too simple and that other signaling
pathways, most notably FGF and Ca2+ signaling, have a modu-
lating and/or instructive role during neural induction (Lamb and
Harland, 1995; Sheng et al., 2003; Stern, 2005; Webb et al.,
2005), which prompted us to study the mechanistic basis of
signal integration during neural induction.
Most of the research on the role of Ca2+ signaling in neural in-
duction has been done in amphibians. It was shown that during
gastrulation, [Ca2+]i levels rise in dorsal, but not ventral, ecto-
derm and that Ca2+ entry via L-type Ca2+ channels and Trp
channels might be critical for neural induction (Leclerc et al.,
2011). Other studies described that at the onset of gastrulation,
there is an increase in IP3 levels in the presumptive neuroecto-
derm pointing toward activation of IP3/Ca
2+ signaling (Kume
et al., 1997). It has also been shown that inhibition of IP3R
signaling results in stage-specific changes in body-axis
patterning. When signaling was blocked at the gastrula stage,
frog embryos showed increased ventralization and a reduction
of anterior structures (Yamaguchi and Shinagawa, 1989). The
observed reduction of anterior structures is reminiscent of
the findings in the CnB1 mutant mice. In addition, activation
of CaN/NFATc signaling by IP3/Ca
2+ has been shown to be
a negative regulator of canonical Wnt signaling, thereby pro-
moting ventral cell fates (Saneyoshi et al., 2002). However, our
studies in mouse embryos, mESCs, and hESCs show that
during mammalian neural induction, CaN integrates FGF-Ca2+
signaling at the level of C-terminal phosphorylation of Smad1/
5 rather than working through the NFATc family of transcription
factors.
Mice mutant for CnB1 and mice in which CaN function was
blocked during gastrulation by pharmacologic inhibition with
CsA display defects in anterior neuroectoderm induction (Fig-
ure 1). In addition, inhibition of CaN activity during the differenti-
ation of ESCs completely blocks neural induction (Figure 2). The
in vivo as well as the in vitro inhibition of CaN with CsA indicates
that CaN activity is required during a defined time windowNeuron 82, 109–of development, which precedes the
initial specification of neuroectoderm.
The observed defects could reflect either
an intrinsic requirement for CaN activity in
neuroectodermal progenitors or a failureof surrounding cells to secrete a factor required for neural differ-
entiation. Our finding that CaN directly modulates the strength
of BMP signaling favors a cell-autonomous role of CaN during
neural induction.
This is further supported by the observation that CaN activity
is required for FGF8 to enhance neural induction of ESCs (Fig-
ure 3). Interestingly, anterior defects, including reduction of
the prosencephalon, eyes, olfactory placodes, and frontonasal
structures, which resemble the phenotype of CnB1 mutant
embryos, have also been associated with a reduction of FGF8
expression (Meyers et al., 1998). However, these findings do
not exclude the possibility of additional roles for CaN in sur-
rounding tissues, such as the nascent mesoderm and definitive
endoderm.
Calcineurin Modulates the Strength of BMP Signaling
Precise regulation of the intensity and duration of BMP
signaling, which is subject to modulation by other signaling
pathways, is critical for specific gene expression patterns
underlying developmental decisions. The results presented in
this manuscript shed new light on how Ca2+ signaling intersects
with the BMP pathway. Our in vitro and in vivo studies indicate
that in the absence of CaN activity, the expression of BMP-
regulated genes is increased, which suggests that CaN modu-
lates either the intensity or the duration of BMP signaling.
Both the intensity and duration of BMP signaling can be
controlled through phosphorylation of Smad proteins. Phos-
phorylation of the linker region by MAPK and GSK3 enhances
degradation of Smad1 and reduces the duration of BMP
signaling (Kretzschmar et al., 1997; Kuroda et al., 2005; Sapkota
et al., 2007). Phosphorylation of the C terminus of R-Smads by
the type I receptor determines the intensity of BMP signaling,
but little is known about how other signaling pathways might
intersect with the BMP pathway to regulate its signal intensity.
We found that CaN reduces the intensity of BMP signaling
by direct dephosphorylation of R-SmadC-term. Our genetic
and pharmacologic data show that CaN dephosphorylates124, April 2, 2014 ª2014 Elsevier Inc. 121
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Calcineurin Signaling Antagonizes the BMP PathwaySmad1/5C-term during early embryonic development of mice and
during neural differentiation of ESCs.
Interestingly, we found little evidence that the linker region of
Smad1 is a substrate for CaN during neural induction. Notably,
EBs also showed no detectable increase of pSmad2/3C-term
following inhibition of CaN (Figure S5; Supplemental Informa-
tion). These studies indicate that CaN is specific for the BMP
branch of the TGF-b superfamily. Remarkably, to date, no
R-Smad phosphatases, which are regulated by signaling path-
ways that oppose the BMP pathway, have been identified and
confirmed by genetic studies. Our finding that BMP signaling is
inhibited by CaN indicates that the default and instructive
models are not mutually exclusive. Rather, the instructive signals
that increase intracellular Ca2+ levels and activate CaN (and
other pathways) also reduce constitutive BMP signaling by
dephosphorylation of Smad1/5C-term. Thus, it appears that the
integrative functions of CaN provide an essential step in neural
induction by bringing the default pathway under local inductive
influences provided by FGF signaling.
For a number of reasons, we hypothesize that the role of CaN
in neural induction is cell autonomous. First, short-term inhibition
of CaN activity in ESCs, HaCaT cells, and early mouse embryos
resulted in pronounced hyperphosphorylation of pSmad1/
5C-term (Figures 4, 5, 6, and S4). Second, we found that
pSmad1/5C-term proteins were direct substrates of CaN phos-
phatase activity (Figure 4H). Third, overexpression of active
CaN in human EBs significantly lowered the level of pSmad1/
5C-term (Figure 4G). Lastly, while we saw increased levels of
BMP4 expression after long-term inhibition of CaN, the levels
of BMP4mRNAwere not elevated following short-term inhibition
with FK/CsA (Figure S4D). The increase of BMP4 mRNA expres-
sion following prolonged inhibition of CaN activity is not unex-
pected, because it is well known that Bmp4 transcription
is under positive-feedback regulation (Karaulanov et al., 2004;
Ramel and Hill, 2012). However, all the experiments on
Smad1/5C-term phosphorylation were performed after short-
term treatments with FK/CsA, at time points during which the
levels of Bmp4 mRNA were not increased.
Calcineurin Antagonizes BMP Signaling during
Gastrulation
Lineage specification during embryonic development is
controlled by the coordinated activation and inhibition of
signaling pathways. Several lines of evidence strongly argue
that CaN directly opposes BMP signaling during gastrulation.
First, embryonic patterning defects of mice lacking CaN activity
were reminiscent of mice carrying mutations in BMP antago-
nists and of mice with increased BMP activity (Bachiller et al.,
2000; Davis et al., 2004) (Figure 1). Second, the expression of
BMP-regulated genes was changed in CnB1 mutant and
CsA-treated embryos (Figure 6). Third, BMP signaling is essen-
tial for the choice between ectodermal and mesodermal fates in
mouse embryos, and embryos mutant for BMP4 and BMPr1a
display ectopic neural differentiation accompanied by suppres-
sion of mesodermal cell fates (Di-Gregorio et al., 2007; Winnier
et al., 1995). Consistent with an antagonistic effect of CaN
on BMP signaling, CnB1 mutant and CsA-treated embryos
showed significantly increased mesodermal and decreased122 Neuron 82, 109–124, April 2, 2014 ª2014 Elsevier Inc.neuroectodermal marker expression (Figures 1 and 6). Smad-
regulated transcription is also implicated in differentiation of
cardiac tissue from mesodermal precursors. The increased
expression of Eomes and Mesp1 suggests increased differ-
entiation along the cardiogenic lineage in CnB1 mutant and
CsA-treated embryos. Lastly, Smad1/5C-term was hyperphos-
phorylated in mouse embryos lacking CaN activity (Figure 6).
In summary, our data indicate that CaN signaling is required
during early embryonic patterning to antagonize BMP signaling,
thus promoting neuroectodermal and restricting mesodermal/
cardiac differentiation.
A more speculative implication of our studies relates to how
gradients of signaling are converted to discreet outcomes or
to different cell fates. In the developing embryo, BMP is pro-
duced locally and then converted to gradients. Cells within
the gradient then develop discreet digital responses to the
analog gradient. These observations indicate that mechanisms
exist that allow threshold discrimination, and models involving
feedback and feed-forward controls have been developed
and partially quantified. Our studies identify a mechanism for
setting a variable threshold for BMP signaling that would be
dependent upon local FGF levels. Although we have called
attention to FGF in inducing CaN activity, other sources of
Ca2+/CaN activation might also contribute to opposing BMP
signaling in the early embryo, including GAP junctions and other
Ca2+ channels. One prediction of our model is that loss of CaN
activity might result in loss or change of cell fates in the devel-
oping embryo. Indeed, this prediction does appear be satisfied
in that the loss of neural fate seen in CnB1-deficient embryos is
accompanied by increased conversion to certain mesodermal
cell fates.
EXPERIMENTAL PROCEDURES
Mouse Lines and In Utero CsA Treatment
CnB1 mutant mice (Neilson et al., 2004) and in utero CsA treatment (Graef
et al., 2001) were previously described. All animal protocols and husbandry
practices were approved by the Institutional Animal Care and Use Committee
at Stanford University.
In Vitro Differentiation of mESCs and hESCs
For mESCs, 46C ESCs (Ying et al., 2003) were plated on gelatin-coated dishes
in ESC medium supplemented with LIF. On d3, dissociated single cells were
seeded into ultra-low attachment dishes in ESCmedium, and EBs were plated
on tissue culture dishes on d7. After 24 hr, the ESC medium was changed
to ITS medium. For hESCs, EBs were formed from a single-cell suspension
of H1 hESCs in AggreWell plates (STEMCELL Technologies). The EBs were
cultured in ultra-low attachment dishes for 4 days and plated on Matrigel-
coated dishes for 6 days. Cell culture conditions and small-molecule treat-
ments are detailed in Supplemental Experimental Procedures.
Flow Cytometry, Microarray, and Data Processing
FACS analysis using a BD FACS Scan system and gene expression analysis
using the Affymetrix Mouse Gene 1.0 ST arrays are detailed in Supplemental
Experimental Procedures.
Quantitative Real-Time PCR, Immunoblots, Immunostaining, and
In Vitro Phosphatase Assay
qRT-PCR was conducted using Power SYBR green PCR Master Mix (Applied
Biosystems) and gene-specific primers listed in Table S2. Antibodies used
for western blots and immunostaining and in vitro phosphatase assays are
detailed in Supplemental Experimental Procedures.
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